The drug targeted inflammation, and its shocking failure has experts questioning whether inflammation really does cause heart disease.
Category: Drugs (Pharmaceuticals)
-
A Promising Heart Drug Fails, Challenging a Long-Held Theory of Disease
The New York Times – Business: -
F.D.A. Approves Moderna’s mRNA Flu Vaccine
The New York Times – Business:The agency had initially refused to even review the application but reversed course after a public outcry.
-
Health Insurance Giants Are Fighting Efforts to Break Them Up
The New York Times – Business:UnitedHealth Group, CVS Health and Cigna are suing states over new laws targeting their pharmacy businesses.
-
Eli Lilly to Buy 3 Vaccine Developers
The New York Times – Business:The drugmaker said it would spend up to $4 billion to acquire small companies exploring vaccines for shingles, Epstein-Barr virus and other pathogens.
-
TrumpRx Adds Generic Drugs, With Mark Cuban, GoodRx and Amazon
The New York Times – Business:President Trump announced the addition of 600 medicines to his online drugstore as he appeals to Americans concerned about high drug prices and affordability.
-
Medicare Coverage for GLP-1 Weight Loss Drugs: Cost, Eligibility and What to Know
The New York Times – Business:What you should know about the federal government’s pilot program offering GLP-1s solely for weight loss.
-
How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough
The New York Times – Business:The new strategy also holds promise for lung and colon tumors. Here’s how scientists discovered it.
-
Trump Plans to Fire F.D.A. Commissioner Marty Makary
The New York Times – Business:Dr. Makary has been a supporter of the Make American Healthy Again Movement but made some enemies in the administration over vaping, the abortion pill and rejections of new drugs.
-
American Factories Lag in Adopting A.I. This Drugmaker Is an Exception.
The New York Times – Business:A Bristol Myers Squibb plant that makes cancer drugs was the only manufacturer in the U.S. recognized for innovation by the World Economic Forum this year.
-
F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer
The New York Times – Business:Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.
-
Two Drugs Stir Hope for Treatment of Deadly Pancreatic Cancer
The New York Times – Business:In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology.